Rosen Law Firm Encourages Aldeyra Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – ALDX

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Aldeyra Therapeutics, Inc. due to allegations of materially misleading business information issued to the investing public [1] Company Summary - Aldeyra Therapeutics, Inc. is facing scrutiny for potentially misleading information that may have affected its securities [1] - Shareholders who purchased Aldeyra securities may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement [1]